We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Existing Drug May Prevent Seizures in Newborns

By HospiMedica staff writers
Posted on 19 Jul 2004
Two studies show that an existing drug called topiramate, used to control seizures in adults and children over the age of three, given to babies immediately after traumatic birth events may prevent them from having cerebral palsy or epilepsy.

One study published in the May 5, 2004, issue of The Journal of Neuroscience, showed that if topiramate was given immediately after a hypoxic-ischemic event, rats were protected from oligodendrocyte injury and showed fewer neuromotor abnormalities than untreated rats. More...
A second study, published in the June 2004 issue of Epilepsia, found that topiramate may also be useful in preventing epilepsy in rats by blocking certain glutamate receptors. Although therapeutic doses of the drug do not appear to alter normal brain development in rats, the safety of topiramate in children under three has not been studied. Trials are needed to determine this.

"The finding that treatment with a drug prevents injury when given after the insult is tremendously significant,” said lead researcher Dr. Frances Jensen, of the Children's Hospital Boston (MA, USA). "Because premature infants are typically maintained in a continuously monitored, intensive care setting, it's feasible to commence treatment even within a few minutes after the insult.”




Related Links:
Children's Hospital

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.